• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

充血性心力衰竭中的交感神经激活:最新综述。

Sympathetic activation in congestive heart failure: an updated overview.

机构信息

Clinica Medica, Department of Medicine and Surgery, University of Milano-Bicocca, Via Pergolesi 33, 20052, Monza, Italy.

Baker IDI Heart and Diabetes Institute, Melbourne, Australia.

出版信息

Heart Fail Rev. 2021 Jan;26(1):173-182. doi: 10.1007/s10741-019-09901-2.

DOI:10.1007/s10741-019-09901-2
PMID:31832833
Abstract

Conclusive evidence demonstrates that the sympathetic nervous system activation is a hallmark of congestive heart failure. This has been shown via a variety of biochemical, neurophysiological, and neuroimaging approaches for studying human sympathetic neural function. The sympathetic activation appears to be an early phenomenon in the clinical course of the disease, closely related to its severity and potentiated by the concomitant presence of other comorbidities, such as obesity, diabetes mellitus, metabolic syndrome, hypertension, and renal failure. The adrenergic overdrive in heart failure is associated with other sympathetic abnormalities, such as the downregulation of beta-adrenergic adrenoreceptors at cardiac level, and exerts unfavorable consequences on the cardiovascular system. These include the endothelial dysfunction, the development of left ventricular hypertrophy, the atherosclerosis development, as well as the generation of atrial and ventricular arrhythmias, and, at very extreme levels of sympathetic activation, the occurrence of microscopic myocardial necrosis. Given the close direct independent relationships detected in heart failure between sympathetic activation and mortality, the adrenergic overdrive has become a target of neuromodulatory therapeutic interventions, which include non-pharmacological, pharmacological, and device-based interventions. For some of these approaches (specifically bilateral renal nerves ablation and carotid baroreceptor stimulation), additional studies are needed to better define their impact on the clinical course of the disease.

摘要

确凿的证据表明,交感神经系统的激活是充血性心力衰竭的一个标志。通过各种生化、神经生理学和神经影像学方法研究人类交感神经功能已经证明了这一点。交感神经的激活似乎是疾病临床过程中的早期现象,与疾病的严重程度密切相关,并因肥胖症、糖尿病、代谢综合征、高血压和肾衰竭等其他合并症的同时存在而加剧。心力衰竭中的肾上腺素能亢进与其他交感神经异常有关,例如心脏水平的β肾上腺素能肾上腺素受体下调,并对心血管系统产生不利影响。这些影响包括内皮功能障碍、左心室肥厚的发展、动脉粥样硬化的发展以及房性和室性心律失常的产生,并且在交感神经极度激活的情况下,还会发生微小的心肌坏死。鉴于在心力衰竭中检测到的交感神经激活与死亡率之间存在直接的密切关系,肾上腺素能亢进已成为神经调节治疗干预的目标,这些干预包括非药物、药物和基于设备的干预。对于其中一些方法(特别是双侧肾神经消融和颈动脉压力感受器刺激),需要进一步的研究来更好地确定它们对疾病临床过程的影响。

相似文献

1
Sympathetic activation in congestive heart failure: an updated overview.充血性心力衰竭中的交感神经激活:最新综述。
Heart Fail Rev. 2021 Jan;26(1):173-182. doi: 10.1007/s10741-019-09901-2.
2
Sympathomodulation in congestive heart failure: From drugs to devices.充血性心力衰竭中的交感神经调节:从药物到器械
Int J Cardiol. 2020 Dec 15;321:118-125. doi: 10.1016/j.ijcard.2020.07.027. Epub 2020 Jul 29.
3
The human sympathetic nervous system: its relevance in hypertension and heart failure.人体交感神经系统:在高血压和心力衰竭中的相关性。
Eur Heart J. 2012 May;33(9):1058-66. doi: 10.1093/eurheartj/ehs041. Epub 2012 Apr 16.
4
Role of the sympathetic nervous system in hypertension and hypertension-related cardiovascular disease.交感神经系统在高血压及高血压相关心血管疾病中的作用。
High Blood Press Cardiovasc Prev. 2014 Jun;21(2):89-105. doi: 10.1007/s40292-014-0056-1. Epub 2014 May 1.
5
Sympathetic overdrive and cardiovascular risk in the metabolic syndrome.代谢综合征中的交感神经过度兴奋与心血管风险
Hypertens Res. 2006 Nov;29(11):839-47. doi: 10.1291/hypres.29.839.
6
Sympathetic control of circulation in hypertension and congestive heart failure.高血压和充血性心力衰竭时循环系统的交感神经控制
Blood Press Suppl. 1998;3:40-5.
7
Sympathetic nervous system activation in essential hypertension, cardiac failure and psychosomatic heart disease.原发性高血压、心力衰竭和心身性心脏病中的交感神经系统激活。
J Cardiovasc Pharmacol. 2000;35(7 Suppl 4):S1-7. doi: 10.1097/00005344-200000004-00001.
8
Central and peripheral sympathetic activation in heart failure.心力衰竭中心和外周交感神经激活。
Cardiovasc Res. 2022 Jun 29;118(8):1857-1871. doi: 10.1093/cvr/cvab222.
9
Sympathetic activation in congestive heart failure: evidence, consequences and therapeutic implications.充血性心力衰竭中的交感神经激活:证据、后果及治疗意义。
Curr Vasc Pharmacol. 2009 Apr;7(2):137-45. doi: 10.2174/157016109787455699.
10
Increased sympathetic nervous system activity and its therapeutic reduction in arterial hypertension, portal hypertension and heart failure.交感神经系统活性增加及其在动脉高血压、门静脉高压和心力衰竭中的治疗性降低。
J Auton Nerv Syst. 1998 Oct 15;72(2-3):210-9. doi: 10.1016/s0165-1838(98)00107-6.

引用本文的文献

1
Renal denervation attenuates cardiac dysfunction in HFpEF by inhibiting the ATP-P2X7-NLRP3 inflammasome axis.肾去神经支配通过抑制ATP-P2X7-NLRP3炎性小体轴减轻射血分数保留的心力衰竭患者的心脏功能障碍。
Basic Res Cardiol. 2025 Sep 16. doi: 10.1007/s00395-025-01138-5.
2
J-shaped association between serum glucose potassium ratio and prognosis in heart failure with preserved ejection fraction with stronger predictive value in non-diabetic patients.射血分数保留的心力衰竭患者中,血清葡萄糖钾比值与预后呈J形关联,在非糖尿病患者中具有更强的预测价值。
Sci Rep. 2024 Dec 2;14(1):29965. doi: 10.1038/s41598-024-81289-y.
3
Treating heart failure by targeting the vagus nerve.

本文引用的文献

1
Advanced heart failure: non-pharmacological approach.晚期心力衰竭:非药物治疗方法。
Heart Fail Rev. 2019 Sep;24(5):779-791. doi: 10.1007/s10741-019-09786-1.
2
Sympathetic neural overdrive in congestive heart failure and its correlates: systematic reviews and meta-analysis.充血性心力衰竭中的交感神经过度驱动及其相关性:系统评价和荟萃分析。
J Hypertens. 2019 Sep;37(9):1746-1756. doi: 10.1097/HJH.0000000000002093.
3
Chronic heart failure: a disease of the brain.慢性心力衰竭:一种脑部疾病。
通过靶向迷走神经治疗心力衰竭。
Heart Fail Rev. 2024 Nov;29(6):1201-1215. doi: 10.1007/s10741-024-10430-w. Epub 2024 Aug 9.
4
Abnormal neurovascular control during central and peripheral chemoreceptors stimulation in heart failure patients with preserved ejection fraction.心力衰竭伴射血分数保留患者中枢和外周化学感受器刺激时神经血管控制异常。
Clin Auton Res. 2024 Jun;34(3):363-374. doi: 10.1007/s10286-024-01041-4. Epub 2024 Jun 15.
5
Pharmacological articles in the German magazine DIE ZEIT (THE TIME)-content, adequacy, and comprehensibility.德国杂志《时代》中的药理学文章——内容、充分性和可理解性。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Sep;397(9):6763-6778. doi: 10.1007/s00210-024-03053-3. Epub 2024 Mar 25.
6
Exercise training outcomes in patients with chronic heart failure with reduced ejection fraction depend on patient background.射血分数降低的慢性心力衰竭患者的运动训练结果取决于患者背景。
Front Cardiovasc Med. 2024 Jan 31;11:1330235. doi: 10.3389/fcvm.2024.1330235. eCollection 2024.
7
Sympatho-adrenergic mechanisms in heart failure: new insights into pathophysiology.心力衰竭中的交感-肾上腺素能机制:病理生理学新见解
Med Rev (2021). 2021 Oct 21;1(1):47-77. doi: 10.1515/mr-2021-0007. eCollection 2021 Oct.
8
Causes and consequences of sympathoexcitation across the lifespan: Physiological or pathological?一生中交感神经兴奋的原因及后果:生理的还是病理的?
Exp Physiol. 2023 Oct;108(10):1235-1237. doi: 10.1113/EP091217. Epub 2023 Sep 15.
9
The sympathetic nervous system in heart failure revisited.心力衰竭中的交感神经系统再探讨。
Heart Fail Rev. 2024 Mar;29(2):355-365. doi: 10.1007/s10741-023-10345-y. Epub 2023 Sep 14.
10
Sympathetic Nervous System and Atherosclerosis.交感神经系统与动脉粥样硬化。
Int J Mol Sci. 2023 Aug 23;24(17):13132. doi: 10.3390/ijms241713132.
Heart Fail Rev. 2019 Mar;24(2):301-307. doi: 10.1007/s10741-018-9747-3.
4
Sympathetic and baroreflex alterations in congestive heart failure with preserved, midrange and reduced ejection fraction.充血性心力衰竭射血分数保留、中间范围和降低时的交感和压力反射改变。
J Hypertens. 2019 Feb;37(2):443-448. doi: 10.1097/HJH.0000000000001856.
5
Obesity and the Obesity Paradox in Heart Failure.肥胖与心力衰竭中的肥胖悖论。
Prog Cardiovasc Dis. 2018 Jul-Aug;61(2):151-156. doi: 10.1016/j.pcad.2018.05.005. Epub 2018 May 28.
6
Implantable devices for heart failure monitoring and therapy.心力衰竭监测和治疗的植入式设备。
Heart Fail Rev. 2018 Nov;23(6):935-944. doi: 10.1007/s10741-018-9687-y.
7
Devices and interventions for the prevention of adverse outcomes of tachycardia on heart failure.用于预防心力衰竭时心动过速不良结局的装置和干预措施。
Heart Fail Rev. 2018 Jul;23(4):507-516. doi: 10.1007/s10741-018-9680-5.
8
Obesity Paradox in Hypertension: Is This Because Sympathetic Activation in Obesity-Hypertension Takes a Benign Form?高血压中的肥胖悖论:这是因为肥胖型高血压中的交感神经激活呈良性形式吗?
Hypertension. 2018 Jan;71(1):22-33. doi: 10.1161/HYPERTENSIONAHA.117.09790. Epub 2017 Nov 20.
9
The autonomic nervous system as a therapeutic target in heart failure: a scientific position statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology.自主神经系统作为心力衰竭的治疗靶点:欧洲心脏病学会心力衰竭协会转化研究委员会的科学立场声明。
Eur J Heart Fail. 2017 Nov;19(11):1361-1378. doi: 10.1002/ejhf.921. Epub 2017 Sep 26.
10
Sympathetic Response and Outcomes Following Renal Denervation in Patients With Chronic Heart Failure: 12-Month Outcomes From the Symplicity HF Feasibility Study.慢性心力衰竭患者肾去神经术后的交感神经反应和结局:Symplicity HF 可行性研究的 12 个月结局。
J Card Fail. 2017 Sep;23(9):702-707. doi: 10.1016/j.cardfail.2017.06.004. Epub 2017 Jun 20.